BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Perrigo Company 

Corporate Office
515 Eastern Avenue
Allegan  Michigan  49010  U.S.A.
Phone: 269-673-8451 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Healthcare






 Company News
Perrigo Company (PRGO) Announces The Closing Of Its Registered Public Offering Of Senior Notes 12/3/2014 11:22:45 AM
Perrigo Company (PRGO) Reinitiates Shipments Of Guaifenesin Extended-Release 600mg Tablets, The Store Brand Equivalent To Mucinex® 600mg Extended-Release Tablets 11/6/2014 8:04:11 AM
Perrigo Company (PRGO) Snatches Up Omega Pharma NV (0OMEP.BR) For $4.5 Billion 11/6/2014 6:21:16 AM
Perrigo Company (PRGO) Announces Quarterly Dividend 11/4/2014 8:10:04 AM
Deal-Starved Perrigo Company (PRGO) In Exclusive Talks To Buy $5 Billion+ Omega Pharma NV (0OMEP.BR) 10/31/2014 6:20:32 AM
Perrigo Company (PRGO) To Release First Quarter Fiscal Year 2015 Results On November 6, 2014 10/23/2014 8:02:43 AM
Perrigo Co. (PRGO) Mum On Published Merger Rumors, Potential Target For Abbott Laboratories (ABT) 7/17/2014 7:58:40 AM
Perrigo Company (PRGO) Announces Receipt Of Requisite Consents For And Pricing Of Its Previously Announced Tender Offer And Consent Solicitation For Its 2.950% Notes Due 2023 11/21/2013 11:13:41 AM
Perrigo Company (PRGO) Announces Pricing of $2,300,000,000 Senior Notes 11/6/2013 10:02:38 AM
Perrigo Company (PRGO) Recalls 18 Batches of Infant Acetaminophen Due to a Potential Defect With the Co-Packaged Oral Syringe 11/4/2013 6:56:43 AM
123